Related content

Antifolate agents: a patent review (2006 – 2010)

By Wright Dennis L   Anderson Amy C  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1293-1308

Informa Healthcare

Access to resources Recommend Favorite

Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 – 2013

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 573-595

Informa Healthcare

Access to resources Recommend Favorite

β-Lactamase inhibitors: a review of the patent literature (2010 – 2013)

By Buynak John D  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1469-1481

Informa Healthcare

Access to resources Recommend Favorite

Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010)

By Marzaro Giovanni   Guiotto Adriano   Chilin Adriana  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 3, 2012-03 ,pp. : 223-252

Informa Healthcare

Access to resources Recommend Favorite

Substituted oxadiazoles: a patent review (2010 – 2012)

By Zarghi Afshin   Hajimahdi Zahra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 9, 2013-09 ,pp. : 1209-1232

Informa Healthcare

Access to resources Recommend Favorite